1. Home
  2. FAF vs BLTE Comparison

FAF vs BLTE Comparison

Compare FAF & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First American Corporation (New)

FAF

First American Corporation (New)

N/A

Current Price

$58.12

Market Cap

6.3B

Sector

Finance

ML Signal

N/A

Logo Belite Bio Inc

BLTE

Belite Bio Inc

N/A

Current Price

$150.33

Market Cap

6.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FAF
BLTE
Founded
1889
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
6.5B
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
FAF
BLTE
Price
$58.12
$150.33
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$78.50
$181.14
AVG Volume (30 Days)
933.5K
166.6K
Earning Date
04-22-2026
03-02-2026
Dividend Yield
3.87%
N/A
EPS Growth
376.19
N/A
EPS
6.00
N/A
Revenue
$7,452,200,000.00
N/A
Revenue This Year
$8.08
N/A
Revenue Next Year
$5.46
$363.39
P/E Ratio
$9.46
N/A
Revenue Growth
21.61
N/A
52 Week Low
$53.95
$49.00
52 Week High
$71.47
$200.00

Technical Indicators

Market Signals
Indicator
FAF
BLTE
Relative Strength Index (RSI) 32.50 31.62
Support Level $54.07 $148.78
Resistance Level $66.97 $161.28
Average True Range (ATR) 2.02 7.74
MACD -1.16 -2.81
Stochastic Oscillator 14.33 11.24

Price Performance

Historical Comparison
FAF
BLTE

About FAF First American Corporation (New)

First American Financial Corp is a financial services business providing insurance through segments: Title insurance and related services segment include real estate insurance, property closing services, third-party handling of real estate funds (escrow), risk mitigation, real estate data products, and related real estate transaction services; The home warranty segment provides residential service contracts that cover residential systems, such as heating and air conditioning systems, and certain appliances against failures that occur as the result of normal usage during the coverage period; and The corporate segment includes investments in venture-stage companies, certain financing facilities and corporate services supporting the company's business operations.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: